BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 201860)

  • 21. Chromosome aberrations acquired in vitro by human B-cell lines. I. Gains and losses of material.
    Steel CM; Shade M; Woodward MA
    J Natl Cancer Inst; 1980 Jul; 65(1):95-9. PubMed ID: 6967125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of ataxia telangiectasia gene dosage on bleomycin-induced chromosome breakage and inhibition of replication in human lymphoblastoid cell lines.
    Kohn PH; Kraemer KH; Buchanan JK
    Exp Cell Res; 1982 Feb; 137(2):387-95. PubMed ID: 6173245
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analyses of relationship among chromosome abnormalities in hematopoietic neoplasms].
    Hashimoto T; Kamada N; Ueoka H; Yamamoto H; Munaka M
    Rinsho Ketsueki; 1987 Nov; 28(11):1990-9. PubMed ID: 3446870
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential segregation patterns of human chromosomes in somatic cell hybrids constructed with human B-lymphocytes and human melanoma cells.
    Glassy MC; Ferrone S
    Cancer Res; 1982 Oct; 42(10):3971-3. PubMed ID: 6980701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenic differences between Burkitt's lymphoma and other EBV-related human lymphoblastoid cell lines.
    Jarvis JE; Ball G; Rickinson AB; Epstein MA
    IARC Sci Publ (1971); 1975; (11 Pt 1):483-9. PubMed ID: 190155
    [No Abstract]   [Full Text] [Related]  

  • 27. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.
    Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM
    Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome abnormalities in a patient with acquired immunodeficiency syndrome (AIDS) and Burkitt lymphoma-leukemia.
    Beverstock GC; Roozendaal KJ; Bödvarsson A; Jonkers GJ; van de Keur D; Wessels H; Webster MR
    Leukemia; 1990 Jun; 4(6):445-7. PubMed ID: 2163000
    [No Abstract]   [Full Text] [Related]  

  • 29. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosome aberrations acquired in vitro by human B-cell lines. II. Distribution of break points.
    Shade M; Woodward MA; Steel CM
    J Natl Cancer Inst; 1980 Jul; 65(1):101-9. PubMed ID: 6967123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the study of the cytogenetics of malignant neoplasms].
    Pogosiants EE; Prigozhina EL
    Vopr Onkol; 1976; 22(1):85-93. PubMed ID: 817511
    [No Abstract]   [Full Text] [Related]  

  • 32. The chromosomes of the EB virus-positive Burkitt cell line P3J.HR1K studied by the fluorescent staining technique.
    Petit P; Verhest A; Lecluse van der Bilt F; Jongsma A
    Pathol Eur; 1972; 7(1):17-21. PubMed ID: 4115493
    [No Abstract]   [Full Text] [Related]  

  • 33. Chromosome abnormalities in Japanese Burkitt lymphoma cell lines.
    Hamasaki K
    Acta Med Okayama; 1982 Feb; 36(1):23-38. PubMed ID: 7064731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RALE051: a novel established cell line of sporadic Burkitt lymphoma.
    L'Abbate A; Iacobucci I; Lonoce A; Turchiano A; Ficarra E; Paciello G; Cattina F; Ferrari A; Imbrogno E; Agostinelli C; Zinzani P; Martinelli G; Derenzini E; Storlazzi CT
    Leuk Lymphoma; 2018 May; 59(5):1252-1255. PubMed ID: 28893133
    [No Abstract]   [Full Text] [Related]  

  • 35. The relation of oncogenesis and cytogenetics in leukemia and lymphoma.
    Pearson M; Rowley JD
    Annu Rev Med; 1985; 36():471-83. PubMed ID: 3888062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomes and cancer: current aspects.
    Jackson LG
    Semin Oncol; 1978 Mar; 5(1):3-10. PubMed ID: 345453
    [No Abstract]   [Full Text] [Related]  

  • 37. Reevaluation of relationship between C chromosome marker and Epstein-Barr virus: chromosome and immunofluorescence analyses of 16 human hematopoietic cell lines.
    Huang CC; Minowada J; Smith RT; Osunkoya BO
    J Natl Cancer Inst; 1970 Oct; 45(4):815-29. PubMed ID: 4104973
    [No Abstract]   [Full Text] [Related]  

  • 38. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced effect of cyclophosphamide on Burkitt lymphoma cell lines in vivo.
    Furukawa M; Huang CC
    Proc Soc Exp Biol Med; 1976 Dec; 153(3):536-8. PubMed ID: 1013168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.